Patents by Inventor Kyungchan JEON

Kyungchan JEON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11903980
    Abstract: The present invention relates to a microorganism which can act as a biomarker of alcoholic fatty liver disease, and relates to a pharmaceutical composition for preventing or treating alcoholic fatty liver disease, a food composition for preventing or improving alcoholic fatty liver disease, or a probiotics composition for preventing or improving alcoholic fatty liver disease, comprising the strain as an active ingredient.
    Type: Grant
    Filed: October 27, 2022
    Date of Patent: February 20, 2024
    Assignee: KOBIOLABS, INC.
    Inventors: Gwangpyo Ko, Boram Seo, Woon Ki Kim, Kyungchan Jeon
  • Publication number: 20230293600
    Abstract: The present invention relates to a Faecalibacterium prausnitzii strain and uses thereof.
    Type: Application
    Filed: August 12, 2021
    Publication date: September 21, 2023
    Inventors: Boram SEO, Kyungchan JEON, Woon Ki KIM, Tae Wook NAM, Gwang Pyo KO, Dukyun KIM
  • Publication number: 20230190829
    Abstract: The present invention relates to a microorganism which can act as a biomarker of alcoholic fatty liver disease, and relates to a pharmaceutical composition for preventing or treating alcoholic fatty liver disease, a food composition for preventing or improving alcoholic fatty liver disease, or a probiotics composition for preventing or improving alcoholic fatty liver disease, comprising the strain as an active ingredient.
    Type: Application
    Filed: October 27, 2022
    Publication date: June 22, 2023
    Inventors: Gwangpyo KO, Boram SEO, Woon Ki KIM, Kyungchan JEON
  • Patent number: 11510948
    Abstract: The present invention relates to a microorganism which can act as a biomarker of alcoholic fatty liver disease, and relates to a pharmaceutical composition for preventing or treating alcoholic fatty liver disease, a food composition for preventing or improving alcoholic fatty liver disease, or a probiotics composition for preventing or improving alcoholic fatty liver disease, comprising the strain as an active ingredient.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: November 29, 2022
    Assignee: KOBIOLABS, INC.
    Inventors: Gwangpyo Ko, Boram Seo, Woon Ki Kim, Kyungchan Jeon
  • Publication number: 20210052674
    Abstract: The present invention relates to a microorganism which can act as a biomarker of alcoholic fatty liver disease, and relates to a pharmaceutical composition for preventing or treating alcoholic fatty liver disease, a food composition for preventing or improving alcoholic fatty liver disease, or a probiotics composition for preventing or improving alcoholic fatty liver disease, comprising the strain as an active ingredient.
    Type: Application
    Filed: September 28, 2018
    Publication date: February 25, 2021
    Inventors: Gwangpyo KO, Boram SEO, Woon Ki KIM, Kyungchan JEON